Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000150915 | SCV000198535 | likely benign | not specified | 2014-06-13 | criteria provided, single submitter | clinical testing | Leu14Leu in exon 1 of LAMP2: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. |
Invitae | RCV001079410 | SCV000636863 | likely benign | Danon disease | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002326863 | SCV002626727 | likely benign | Cardiovascular phenotype | 2019-11-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV000150915 | SCV001926046 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000535295 | SCV001931720 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000535295 | SCV001979469 | likely benign | not provided | no assertion criteria provided | clinical testing |